208 related articles for article (PubMed ID: 10075686)
1. L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.
Elbrecht A; Chen Y; Adams A; Berger J; Griffin P; Klatt T; Zhang B; Menke J; Zhou G; Smith RG; Moller DE
J Biol Chem; 1999 Mar; 274(12):7913-22. PubMed ID: 10075686
[TBL] [Abstract][Full Text] [Related]
2. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
[TBL] [Abstract][Full Text] [Related]
3. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
Berger J; Leibowitz MD; Doebber TW; Elbrecht A; Zhang B; Zhou G; Biswas C; Cullinan CA; Hayes NS; Li Y; Tanen M; Ventre J; Wu MS; Berger GD; Mosley R; Marquis R; Santini C; Sahoo SP; Tolman RL; Smith RG; Moller DE
J Biol Chem; 1999 Mar; 274(10):6718-25. PubMed ID: 10037770
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
Leesnitzer LM; Parks DJ; Bledsoe RK; Cobb JE; Collins JL; Consler TG; Davis RG; Hull-Ryde EA; Lenhard JM; Patel L; Plunket KD; Shenk JL; Stimmel JB; Therapontos C; Willson TM; Blanchard SG
Biochemistry; 2002 May; 41(21):6640-50. PubMed ID: 12022867
[TBL] [Abstract][Full Text] [Related]
5. A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus.
Berger J; Patel HV; Woods J; Hayes NS; Parent SA; Clemas J; Leibowitz MD; Elbrecht A; Rachubinski RA; Capone JP; Moller DE
Mol Cell Endocrinol; 2000 Apr; 162(1-2):57-67. PubMed ID: 10854698
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
Johnson TE; Vogel R; Rutledge SJ; Rodan G; Schmidt A
Endocrinology; 1999 Jul; 140(7):3245-54. PubMed ID: 10385421
[TBL] [Abstract][Full Text] [Related]
7. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
Berger J; Tanen M; Elbrecht A; Hermanowski-Vosatka A; Moller DE; Wright SD; Thieringer R
J Biol Chem; 2001 Apr; 276(16):12629-35. PubMed ID: 11278270
[TBL] [Abstract][Full Text] [Related]
10. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
12. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
13. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
Berger JP; Petro AE; Macnaul KL; Kelly LJ; Zhang BB; Richards K; Elbrecht A; Johnson BA; Zhou G; Doebber TW; Biswas C; Parikh M; Sharma N; Tanen MR; Thompson GM; Ventre J; Adams AD; Mosley R; Surwit RS; Moller DE
Mol Endocrinol; 2003 Apr; 17(4):662-76. PubMed ID: 12554792
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors.
Johnson TE; Holloway MK; Vogel R; Rutledge SJ; Perkins JJ; Rodan GA; Schmidt A
J Steroid Biochem Mol Biol; 1997; 63(1-3):1-8. PubMed ID: 9449199
[TBL] [Abstract][Full Text] [Related]
15. Altering PPARgamma ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers.
Samarasinghe SP; Sutanto MM; Danos AM; Johnson DN; Brady MJ; Cohen RN
Obesity (Silver Spring); 2009 May; 17(5):965-72. PubMed ID: 19165156
[TBL] [Abstract][Full Text] [Related]
16. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
17. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.
Zhang B; Berger J; Zhou G; Elbrecht A; Biswas S; White-Carrington S; Szalkowski D; Moller DE
J Biol Chem; 1996 Dec; 271(50):31771-4. PubMed ID: 8943212
[TBL] [Abstract][Full Text] [Related]
18. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
[TBL] [Abstract][Full Text] [Related]
19. Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
Rival Y; Stennevin A; Puech L; Rouquette A; Cathala C; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Wurch T; Junquéro D
J Pharmacol Exp Ther; 2004 Nov; 311(2):467-75. PubMed ID: 15273253
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
